The acute phase protein C-reactive protein (CRP) at baseline predicted changes in fatigue as measured by Functional Assessment of Cancer Therapy—Fatigue Scale in patients receiving chemotherapy and was independent of depression. This evidence concerns the gene CRP and major depressive disorder.